March 11, 2013 Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

[at noodls] – March 11, 2013 Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation Quebec City, Canada, March 11, 2013 – Aeterna Zentaris … more

View todays social media effects on AEZS

View the latest stocks trending across Twitter. Click to view dashboard

See who AEterna is hiring next, click here to view